N-甲基-d-酸盐受体:结构,功能和在有机化合物中毒中的作用
Dora Kolić1, Zrinka Kovarik1,2
1Division of Toxicology, Institute for Medical Research and Occupational Health, Zagreb, Croatia.
BioFactors (Oxford, England)
|February 28, 2024
概括
有机化合物中毒会通过过度刺激大脑受体引起发作. 抑制N-甲基-d-酸盐受体 (NMDARs) 可以预防神经毒性和炎症,提供新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性有机化合物 (OP) 中毒导致胆性危机和严重的发作.
- 发作是由于胆固醇过度刺激引起的,而这种过度刺激则会被谷氨酸系统过度活跃所加剧.
- 过高的乙胆过度刺激肌肉酶受体,导致神经元过度兴奋和通过N-甲基-d-酸盐受体 (NMDARs) 输入.
研究的目的:
- 审查NMDARs在OP诱导的神经毒性的有害作用.
- 突出NMDAR抑制在减轻OP神经毒性和炎症方面的重要性.
- 探索NMDAR抑制剂作为OP中毒的潜在治疗方法.
主要方法:
- 对NMDAR结构和功能现有文献的审查.
- 对NMDAR参与OP中毒机制的分析.
- 作为治疗策略的NMDAR抑制的评估.
主要成果:
- 在OP诱导的兴奋毒性,氧化应激和神经炎症中,NMDARs起着中心作用.
- 过度激活NMDAR有助于反复发作,神经元死亡和神经损伤.
- 抑制NMDAR有效抑制神经毒性并调节炎症反应.
结论:
- NMDARs是预防OP诱导的神经毒性的关键目标.
- NMDAR抑制剂为OP中毒提供了一个有前途的治疗途径,解决了当前治疗方法的局限性.
- 向NMDAR可以克服抗药性并减轻OP中毒的炎症反应.
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
856
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
856
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
565
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
565
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Cholinergic Receptors: Muscarinic
2.2K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.2K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
958
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
958
Opioid Receptors: Overview
808
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
808


